Stocks
5042CRFN
YHDHealthcareBiotechnology
A clinical-stage biopharmaceutical company developing therapies for rare genetic disorders, with a focus on central nervous system conditions. Its lead programs target diseases with high unmet medical need, and investors track it for its pipeline catalysts and potential regulatory milestones.
Congressional Interest in 5042 (CRFN)
1 member of Congress has disclosed 1 trade in 5042 (CRFN), a Healthcare company. The buy/sell breakdown shows 1 purchase versus 0 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
1
Unique Politicians
1
Buys
1
Sells
0
Who in Congress Is Trading CRFN?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2016-11-03 | MIKE KELLY | buy | $1K-$15K |